KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Non Operating Income (2016 - 2025)

Evolent Health has reported Non Operating Income over the past 9 years, most recently at $252000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $252000.0 for Q4 2025, down 33.86% from a year ago — trailing twelve months through Dec 2025 was $249000.0 (up 3.32% YoY), and the annual figure for FY2025 was $249000.0, up 3.32%.
  • Non Operating Income for Q4 2025 was $252000.0 at Evolent Health, up from $80000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for EVH hit a ceiling of $381000.0 in Q4 2024 and a floor of -$345000.0 in Q3 2022.
  • Median Non Operating Income over the past 5 years was -$38000.0 (2021), compared with a mean of -$7100.0.
  • Peak annual rise in Non Operating Income hit 1750.0% in 2022, while the deepest fall reached 741.46% in 2022.
  • Evolent Health's Non Operating Income stood at -$73000.0 in 2021, then changed by 0.0% to -$73000.0 in 2022, then plummeted by 201.37% to -$220000.0 in 2023, then soared by 273.18% to $381000.0 in 2024, then crashed by 33.86% to $252000.0 in 2025.
  • The last three reported values for Non Operating Income were $252000.0 (Q4 2025), $80000.0 (Q3 2025), and -$35000.0 (Q2 2025) per Business Quant data.